# Persistent neutrophil activation despite count normalization suggests immune dysregulation in exertional heat stroke

**Authors:** Yue Wang, Siya Xu, Zhongzhi Tang, Jie Liu

PMC · DOI: 10.3389/fimmu.2025.1718617 · Frontiers in Immunology · 2026-02-04

## TL;DR

This study shows that neutrophils in exertional heat stroke patients remain activated even after their counts return to normal, indicating ongoing immune dysregulation.

## Contribution

The study reveals a dissociation between neutrophil recruitment and activation in EHS, highlighting prolonged immune dysregulation.

## Key findings

- EHS patients had elevated neutrophil counts and inflammatory markers at onset.
- MPO and NE levels remained high even after neutrophil counts normalized.
- CXCL1/CXCL2 levels strongly correlated with MPO/NE at disease onset.

## Abstract

The role of neutrophils in exertional heat stroke (EHS), a life-threatening condition characterized by systemic inflammation, remains poorly defined. This study aimed to characterize the longitudinal profiles of neutrophil recruitment and activation in EHS patients.

In this retrospective study with a small sample size, we analyzed clinical data and biobanked serum samples from 18 EHS patients and 18 matched healthy controls. Serum levels of interleukin-6 (IL-6), IL-8, IL-17, granulocyte colony-stimulating factor (G-CSF), CXCL1, CXCL2, C-reactive protein (CRP), serum amyloid A (SAA), myeloperoxidase (MPO), and neutrophil elastase (NE) were quantified by ELISA at onset and on days 3, 5, and 7 post-treatment.

At onset, EHS patients exhibited significant neutrophilia and elevated levels of IL-8, CXCL1, CXCL2, and IL-17 (all P < 0.05). While neutrophil counts normalized within days post-treatment, MPO and NE levels remained persistently and significantly elevated throughout the 7-day follow-up compared to controls (all P < 0.0001). Furthermore, strong positive correlations were observed between the levels of CXCL1/CXCL2 and MPO/NE at disease onset.

In this exploratory study, our findings reveal a dissociation between neutrophil recruitment and activation in EHS. The persistent elevation of MPO and NE long after count normalization suggests a prolonged state of neutrophil dysregulation that could contribute to both acute tissue injury and long-term immune complications in EHS survivors.

## Linked entities

- **Proteins:** IL6 (interleukin 6), IL6 (interleukin 6), CXCL8 (C-X-C motif chemokine ligand 8), IL17A (interleukin 17A), CSF3 (colony stimulating factor 3), CXCL1 (C-X-C motif chemokine ligand 1), CXCL2 (C-X-C motif chemokine ligand 2), CRP (C-reactive protein), SAA1 (serum amyloid A1), MPO (myeloperoxidase), ELANE (elastase, neutrophil expressed)
- **Diseases:** exertional heat stroke (MONDO:0018752)

## Full-text entities

- **Genes:** CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, MB (myoglobin) [NCBI Gene 4151] {aka MYOSB, PVALB}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, SAA [NCBI Gene 6287], CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CXCR2 (C-X-C motif chemokine receptor 2) [NCBI Gene 3579] {aka CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, TNNT2 (troponin T2, cardiac type) [NCBI Gene 7139] {aka CMD1D, CMH2, CMPD2, LVNC6, RCM3, TnTC}, CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920] {aka CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2}, ELANE (elastase, neutrophil expressed) [NCBI Gene 1991] {aka ELA2, GE, HLE, HNE, NE, PMN-E}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, MPO (myeloperoxidase) [NCBI Gene 4353], SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}
- **Diseases:** EHS (MESH:D018882), convulsions (MESH:D012640), ischemia (MESH:D007511), neurological disorders (MESH:D009461), Stroke (MESH:D020521), delirium (MESH:D003693), Organ Failure (MESH:D009102), central nervous system dysfunction (MESH:D002493), central nervous system (CNS) abnormalities (MESH:D063647), SIRS (MESH:D018746), Failure (MESH:D051437), inflammation (MESH:D007249), sepsis (MESH:D018805), tissue damage (MESH:D017695), coma (MESH:D003128), Heat Stroke (MESH:D018883), immune dysregulation (OMIM:614878), ) dysfunction (MESH:D006331), liver dysfunction (MESH:D017093), systemic (MESH:D015619), muscle injury (MESH:D009135), organ damage (MESH:D000092124), leukocytosis (MESH:D007964), immune dysfunction (MESH:D007154), infection (MESH:D007239), coagulation abnormalities (MESH:D001778), neutrophilia (MESH:C563010), neutrophil (MESH:C564275), acute tissue injury (MESH:D001930), reperfusion injury (MESH:D015427), rheumatoid arthritis (MESH:D001172)
- **Chemicals:** bilirubin (MESH:D001663), reactive oxygen species (MESH:D017382), DBIL (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913518/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913518/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913518/full.md

---
Source: https://tomesphere.com/paper/PMC12913518